Effects of 5-Aminolevulinic Acid on Glucose Metabolism
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
35 Years to 70 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Type 2 diabetic patients on medication
HbA1c ≤ 9.0% (as JDS values, which is equivalent to HbA1c ≤ 9.4% as NGSP values)
On stable treatment of diabetes for at least the last 3 months
With permission to attend the clinical trial from the primary doctor
On insulin therapy
BMI ≤ 18 kg/m2 or ≥ 30 kg/m2
History of porphyria, hemochromatosis, or viral hepatitis
Pregnant or nursing a child
Renal or hepatic dysfunction
Participation in any clinical trial within 90 days of the commencement of the trial